Integral Diagnostics Limited (ASX:IDX)
2.180
-0.050 (-2.24%)
Aug 7, 2026, 4:10 PM AEST
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 812.02 million as of August 7, 2026. Its market cap has decreased by -20.38% in one year.
Market Cap
812.02M
Enterprise Value
1.38B
Revenue
767.82M
Ranking
n/a
PE Ratio
58.11
Stock Price
2.18
ChartMarket Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 812.02M, an increase of 207.85%. That is a compound annual growth rate of 10.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 812.02M | -14.22% |
| Dec 31, 2025 | 946.69M | -12.49% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 10.91B |
| Australian Clinical Labs | 448.96M |
| Healius | 297.72M |
| Monash IVF Group | 268.85M |
| Cryosite | 58.57M |
| Microba Life Sciences | 35.86M |
| BCAL Diagnostics | 27.65M |
| INOVIQ | 27.45M |